Given its role in autophagy and tumor suppression, Beclin 1 is a promising target for cancer therapy. Strategies to enhance Beclin 1 expression or restore its function could potentially suppress tumor growth. However, the dual role of autophagy in cancer—both promoting and inhibiting tumor growth—necessitates careful consideration in therapeutic design.
